BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs. Based on our proprietary basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with 80-90% improvement of standard turnaround time. Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient. BactoByte has technology validation and partnerships with leading medical centers.
View Top Employees from BactoByte LTDWebsite | http://www.bactobyte.com/ |
Revenue | $600000 |
Employees | 7 (4 on RocketReach) |
Founded | 2017 |
Phone | +972 52-863-0661 |
Technologies |
HTML,
Nginx,
G Suite
+3 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Health Diagnostics, Medical Device |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies |
Looking for a particular BactoByte LTD employee's phone or email?
The BactoByte LTD annual revenue was $600000 in 2024.
Vladimir Glukhman is the Chief Technology Officer, Co-Founder of BactoByte LTD.
4 people are employed at BactoByte LTD.
BactoByte LTD is based in Jerusalem, Jerusalem.
The NAICS codes for BactoByte LTD are [54, 5417, 541, 541714, 54171].
The SIC codes for BactoByte LTD are [87, 873].